No Undisclosed Events or Circumstances. No event, liability, development or circumstance has occurred or exists, or is reasonably expected to exist or occur with respect to the Company, any of its Subsidiaries or any of their respective businesses, properties, liabilities, prospects, operations (including results thereof) or condition (financial or otherwise), that (i) would be required to be disclosed by the Company under applicable securities laws in the Registration Statement or the Prospectus, which has not been disclosed or incorporated by reference in the Registration Statement and the Prospectus, or (ii) would reasonably be expected to have a Material Adverse Effect.
Appears in 20 contracts
Sources: Common Stock Purchase Agreement (Cero Therapeutics Holdings, Inc.), Common Share Purchase Agreement (Aptose Biosciences Inc.), Common Share Purchase Agreement (Aptose Biosciences Inc.)
No Undisclosed Events or Circumstances. No event, liability, development or circumstance has occurred or exists, or is reasonably expected to exist or occur with respect to the Company, any of its Subsidiaries or any of their respective businesses, properties, liabilities, prospects, operations (including results thereof) or condition (financial or otherwise), that (i) would be required to be disclosed by the Company under applicable securities laws in the Registration Statement or the Prospectus, which has not been disclosed or incorporated by reference in the Registration Statement and the ProspectusFiled Commission Documents, or (ii) would reasonably be expected to have a Material Adverse Effect.
Appears in 3 contracts
Sources: Common Stock Purchase Agreement (Onconetix, Inc.), Common Stock Purchase Agreement (Onconetix, Inc.), Common Stock Purchase Agreement (Inspire Veterinary Partners, Inc.)
No Undisclosed Events or Circumstances. No event, liability, development or circumstance has occurred or exists, or is reasonably expected to exist or occur with respect to the Company, any of its Subsidiaries or any of their respective businesses, properties, liabilities, prospects, operations (including results thereof) or condition (financial or otherwise), that (i) would be required to be disclosed by the Company under applicable securities laws in the Registration Statement or the ProspectusCommission Documents, which has not been disclosed or incorporated by reference in the Registration Statement and the ProspectusCommission Documents, or (ii) would reasonably be expected to have a Material Adverse Effect.
Appears in 3 contracts
Sources: Common Stock Purchase Agreement (Windtree Therapeutics Inc /De/), Common Stock Purchase Agreement (Windtree Therapeutics Inc /De/), Common Stock Purchase Agreement (Spectaire Holdings Inc.)
No Undisclosed Events or Circumstances. No event, liability, development or circumstance has occurred or exists, or is reasonably expected to exist or occur with respect to the Company, Company or any of its Subsidiaries or any of their respective businesses, properties, liabilities, prospects, operations (including results thereof) or condition (financial or otherwise), that (i) would be required to be disclosed by the Company under applicable securities laws in the Registration Statement or the ProspectusProspectus or the Prospectus Supplement, which has not been disclosed or incorporated by reference in the Registration Statement and the ProspectusProspectus or the Prospectus Supplement, or (ii) would reasonably be expected to have a Material Adverse Effect.
Appears in 2 contracts
Sources: Common Stock Purchase Agreement (Annovis Bio, Inc.), Common Stock Purchase Agreement (ProPhase Labs, Inc.)
No Undisclosed Events or Circumstances. No event, liability, development or circumstance has occurred or exists, or is reasonably expected to exist occur or occur exist, with respect to the Company, any of its Subsidiaries or any of their respective businesses, properties, liabilities, prospects, operations (including results thereof) or condition (financial or otherwise), that (ia) would be required to be disclosed by the Company under applicable securities laws in the Registration Statement or the Prospectus, which has not been disclosed or incorporated by reference in the Registration Statement and the Prospectus, or (iib) would reasonably be expected to have a Material Adverse Effect.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Super League Gaming, Inc.)
No Undisclosed Events or Circumstances. No event, liability, development or circumstance has occurred or exists, or is reasonably expected to exist or occur with respect to the Company, any of its Subsidiaries or any of their respective businesses, properties, liabilities, prospects, operations (including results thereof) or condition (financial or otherwise), that (i) except as set forth in Schedule 4.9, would be required to be disclosed by the Company under applicable securities laws in the Registration Statement or the Prospectus, which has not been disclosed or incorporated by reference in the Registration Statement and the ProspectusFiled Commission Documents, or (ii) would reasonably be expected to have a Material Adverse Effect.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (SRx Health Solutions, Inc.)